Clinical Trial

Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
Never started
Summary
This is a prospective, single-arm intervention trial whereby we will test the safety and efficacy of performing pulmonary vein isolation (PVI) using pulsed field ablation (PFA) in adult patients with congenital heart disease (CHD) who are presenting for atrial tachycardia (AT) ablation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-05.
Status change: Not Yet Recruiting → Withdrawn 2026-07-13
Trial Details
NCT Number NCT06969378
Lead Sponsor Boston Children's Hospital
Collaborators: Brigham and Women's Hospital
Conditions Atrial Fibrillation, Atrial Tachycardia, Atrial Flutter, Congenital Heart Disease, Pulmonary Vein Isolation, Pulsed Field Ablation, Catheter Ablation
Start Date 2025-07-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-14